Archive · 3 Jun 2025
Sun Pharma's Halol Unit Faces Surprise US FDA Inspection
Sun Pharmaceutical Industries Ltd.'s Halol facility is currently being inspected by three inspectors from the US Food and Drug Administration (FDA).
The Halol unit, which is a major manufacturing site for Sun Pharma, previously underwent inspection in May 2022.
The facility is currently under an import alert due to a warning letter from the US FDA.
The company has stated that they do not comment on the schedule of regulatory inspections.
Shares of Sun Pharmaceutical Industries Ltd.
are trading slightly lower.
A surprise inspection is underway at Sun Pharma's Halol facility.
Three US FDA inspectors are conducting the inspection.
The Halol unit was last inspected in May 2022.
The facility is currently under an import alert.
Sun Pharma declined to comment on the inspection schedule.
- Who
- US FDA inspectors
- What
- USFDA inspection at Sun Pharma's Halol unit
- When
- Currently underway
- Where
- Halol facility of Sun Pharmaceutical Industries Ltd.
- Why
- To assess the facility
- Company
- Sun Pharmaceutical Industries Ltd.
- Facility
- Halol unit
- Inspectors
- Three US FDA inspectors
- Last Inspection
- May 2022
- Current Status
- Under import alert
- Stock Movement
- Down 0.26%